You are here: Industry Insights > Johnson & Johnson

News List

Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Publishe firstwordpharma
July 15, 2021
Interim results from a Phase 1/2a sub-study published in the New England Journal of Medicine(NEJM) demonstrated that both humoral (antibody) and cellular (T-cell) immune responses generated by the Johnson & Johnson single-shot COVID-19 vaccine
Positive new data for Johnson & Johnson single-shot COVID-19 vaccine on activity against Delta variant and long-lasting durability of response worldpharmanews
July 08, 2021
Johnson & Johnson announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.
Johnson & Johnson to pay $230m to settle opioid-related claims pharmaceutical-business-review
July 02, 2021
Johnson & Johnson (J&J) has reached a $230m agreement to settle the opioid-related claims with the New York State and its participating subdivisions Nassau County and Suffolk County.
EU drug regulator records 415 cases of possible rare blood clotting firstwordpharma
June 18, 2021
The EU drug regulator said on Thursday it has received reports of 415 possible cases of thrombosis with thrombocytopenia syndrome in the EEA, out of over 50 million people who have gotten AstraZeneca and Johnson & Johnson's COVID-19 vaccines.
Johnson & Johnson to donate 200,000 vaccine regimens to curb Ebola outbreak europeanpharmaceuticalreview
May 18, 2021
To prevent the spread of the Ebola virus in West Africa, Johnson & Johnson is donating vaccines for a WHO early access clinical programme.
Johnson & Johnson 1Q Results contractpharma
April 21, 2021
Pharmaceutical sales up 10% in the quarter driven by DARZALEX, STELARA, INVEGA SUSTENNA, and IMBRUVICA.
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Task Team for the Company's COVID-19 Vaccine Candidate prnasia
March 29, 2021
Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an agreement with the African Vaccine Acquisition Task Team (AVATT) to make available up to 220 million doses of its single-shot COVID-19 ...
Johnson & Johnson announces aingle-ahot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its Phase 3 ENSEMBLE trial worldpharmanews
March 09, 2021
Johnson & Johnson announced top line efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key ...
Merck to support manufacturing of Johnson & Johnson’s Covid-19 vaccine pharmaceutical-technology
March 04, 2021
Merck (MSD) has signed an agreement with Janssen Pharmaceuticals (JPI), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to support the manufacturing and supply of its Covid-19 vaccine.
Fauci says of Johnson & Johnson COVID-19 vaccine: ‘I would take it’ expresspharma
March 02, 2021
Anthony Fauci, the top US infectious disease official, said on Sunday he would take the newly approved Johnson & Johnson COVID-19 vaccine, as he encouraged Americans to accept whatever version was available.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page